Frank Morgan
Stock Analyst at RBC Capital
(0.92)
# 3,973
Out of 5,124 analysts
57
Total ratings
46.15%
Success rate
-11.02%
Average return
Main Sectors:
Stocks Rated by Frank Morgan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EHTH eHealth | Maintains: Sector Perform | $13 → $11 | $4.60 | +139.13% | 4 | Nov 25, 2024 | |
| UHS Universal Health Services | Maintains: Sector Perform | $222 → $211 | $218.02 | -3.22% | 4 | Oct 28, 2024 | |
| HUM Humana | Maintains: Outperform | $415 → $353 | $256.13 | +37.82% | 4 | Apr 25, 2024 | |
| CI The Cigna Group | Upgrades: Outperform | $327 → $354 | $275.23 | +28.62% | 4 | Feb 5, 2024 | |
| AVAH Aveanna Healthcare Holdings | Downgrades: Sector Perform | $7 → $3 | $8.17 | -63.28% | 2 | Nov 21, 2022 | |
| ACHC Acadia Healthcare Company | Maintains: Outperform | $84 → $94 | $14.19 | +562.44% | 1 | Aug 1, 2022 | |
| HCA HCA Healthcare | Maintains: Outperform | $256 → $249 | $466.86 | -46.66% | 3 | Jul 25, 2022 | |
| THC Tenet Healthcare | Maintains: Outperform | $104 → $99 | $198.72 | -50.18% | 2 | Jul 25, 2022 | |
| SEM Select Medical Holdings | Maintains: Outperform | $47 → $42 | $14.85 | +182.83% | 1 | Mar 7, 2022 | |
| CHE Chemed | Maintains: Outperform | $609 → $579 | $427.86 | +35.32% | 3 | Mar 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Sector Perform | $150 → $30 | $2.15 | +1,295.35% | 2 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $13 → $3 | $1.41 | +112.77% | 3 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $42 → $35 | $23.82 | +46.94% | 2 | Nov 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $44 → $37 | $28.15 | +31.44% | 3 | Nov 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $97 → $107 | $79.36 | +34.83% | 1 | Nov 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $13 → $9 | $7.43 | +21.13% | 1 | Nov 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $137 → $124 | $107.35 | +15.51% | 1 | Nov 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $96 | $174.13 | -44.87% | 3 | Oct 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $113 → $111 | $113.61 | -2.30% | 3 | Oct 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $473 → $476 | $330.11 | +44.19% | 1 | Oct 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $65 → $41 | $12.95 | +216.60% | 2 | Aug 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Perform | $7 → $8 | $10.79 | -25.86% | 4 | Aug 9, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $102 → $104 | $106.14 | -2.02% | 1 | Jul 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $12 → $21 | $3.12 | +573.08% | 1 | Jun 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $18 → $20 | $15.45 | +29.45% | 1 | Aug 10, 2018 |
eHealth
Nov 25, 2024
Maintains: Sector Perform
Price Target: $13 → $11
Current: $4.60
Upside: +139.13%
Universal Health Services
Oct 28, 2024
Maintains: Sector Perform
Price Target: $222 → $211
Current: $218.02
Upside: -3.22%
Humana
Apr 25, 2024
Maintains: Outperform
Price Target: $415 → $353
Current: $256.13
Upside: +37.82%
The Cigna Group
Feb 5, 2024
Upgrades: Outperform
Price Target: $327 → $354
Current: $275.23
Upside: +28.62%
Aveanna Healthcare Holdings
Nov 21, 2022
Downgrades: Sector Perform
Price Target: $7 → $3
Current: $8.17
Upside: -63.28%
Acadia Healthcare Company
Aug 1, 2022
Maintains: Outperform
Price Target: $84 → $94
Current: $14.19
Upside: +562.44%
HCA Healthcare
Jul 25, 2022
Maintains: Outperform
Price Target: $256 → $249
Current: $466.86
Upside: -46.66%
Tenet Healthcare
Jul 25, 2022
Maintains: Outperform
Price Target: $104 → $99
Current: $198.72
Upside: -50.18%
Select Medical Holdings
Mar 7, 2022
Maintains: Outperform
Price Target: $47 → $42
Current: $14.85
Upside: +182.83%
Chemed
Mar 4, 2022
Maintains: Outperform
Price Target: $609 → $579
Current: $427.86
Upside: +35.32%
Mar 3, 2022
Downgrades: Sector Perform
Price Target: $150 → $30
Current: $2.15
Upside: +1,295.35%
Feb 8, 2022
Maintains: Sector Perform
Price Target: $13 → $3
Current: $1.41
Upside: +112.77%
Nov 17, 2021
Maintains: Sector Perform
Price Target: $42 → $35
Current: $23.82
Upside: +46.94%
Nov 10, 2021
Maintains: Outperform
Price Target: $44 → $37
Current: $28.15
Upside: +31.44%
Nov 4, 2021
Maintains: Outperform
Price Target: $97 → $107
Current: $79.36
Upside: +34.83%
Nov 3, 2021
Maintains: Outperform
Price Target: $13 → $9
Current: $7.43
Upside: +21.13%
Nov 3, 2021
Maintains: Outperform
Price Target: $137 → $124
Current: $107.35
Upside: +15.51%
Oct 29, 2021
Maintains: Outperform
Price Target: $100 → $96
Current: $174.13
Upside: -44.87%
Oct 29, 2021
Maintains: Sector Perform
Price Target: $113 → $111
Current: $113.61
Upside: -2.30%
Oct 15, 2021
Maintains: Outperform
Price Target: $473 → $476
Current: $330.11
Upside: +44.19%
Aug 18, 2021
Maintains: Outperform
Price Target: $65 → $41
Current: $12.95
Upside: +216.60%
Aug 9, 2021
Maintains: Sector Perform
Price Target: $7 → $8
Current: $10.79
Upside: -25.86%
Jul 29, 2021
Maintains: Outperform
Price Target: $102 → $104
Current: $106.14
Upside: -2.02%
Jun 10, 2021
Upgrades: Outperform
Price Target: $12 → $21
Current: $3.12
Upside: +573.08%
Aug 10, 2018
Maintains: Outperform
Price Target: $18 → $20
Current: $15.45
Upside: +29.45%